BioCentury
ARTICLE | Company News

Hypnion, Eli Lilly deal

March 12, 2007 7:00 AM UTC

LLY will acquire Hypnion for an undisclosed amount of cash. Hypnion's oral HY10275 is in Phase II testing to treat insomnia by improving both sleep induction and maintenance. In January, Phase II data...